MedTrace Logo

Emollient Therapy for Premature Infants in Zimbabwe

NCT05461404 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2023-04-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of topical emollient treatments in improving neonatal growth and mortality rates.

Conditions

  • Very Low Birth Weight Infant

Interventions

OTHER

Topical Emollient Therapy

Application of high-linoleate (\>60% linoleic acid) SSO to the epidermis.

Sponsors & Collaborators

Principal Investigators

  • Hilda A. Mujuru, MBChB, MMed, MSc · University of Zimbabwe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2025-05-31
Completion
2025-12-31

Countries

  • Zimbabwe

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461404 on ClinicalTrials.gov